Rockefeller Capital Management
STIM icon

Rockefeller Capital Management’s Neuronetics STIM Stock Holding History

Rockefeller Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Hold
1,500
– – ﹤0.01% 4435
2026
Q1 		$2.17K Hold
1,500
– – ﹤0.01% 4401
2025
Q4 		$2.07K Hold
1,500
– – ﹤0.01% 4308
2025
Q3 		$4.09K Buy
+1,500
New +$5.33K ﹤0.01% 3932

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Rockefeller Capital Management's STIM Position: Q2 2026 in Review

Rockefeller Capital Management held its Neuronetics (STIM) position steady in Q2 2026 at 1,500 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4435.

Rockefeller Capital Management first reported a position in STIM in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.09K in Q3 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Rockefeller Capital Management held 1,500 shares of Neuronetics worth $1.95K as of Q2 2026.
  • Rockefeller Capital Management left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4435 holding.
  • Rockefeller Capital Management first reported a position in Neuronetics in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Neuronetics position peaked at $4.09K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.